Overview

• Specialty products maker's Q4 sales missed analyst expectations

• Company achieved $222 mln debt reduction in fiscal 2025

• Record production year in Specialty Products & Solutions segment

Outlook

• Calumet plans to complete MaxSAF 150 expansion in Q2 2026

• Company expects continued growth driven by structural cost reductions

Result Drivers

• COST REDUCTIONS - Calumet achieved $100 mln in cost reductions, aiding in $222 mln debt reduction and nearly 30% EBITDA growth

• SPECIALTY PRODUCTS GROWTH - Record production and strong margins in Specialty Products & Solutions segment boosted results

• RENEWABLES CHALLENGES - Montana Renewables faced low industry diesel margins but benefited from cost reductions

Company press release: ID:nPn7sSVLMa

Key Details

Analyst Coverage

• The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 3 "strong buy" or "buy", 3 "hold" and no "sell" or "strong sell"

• The average consensus recommendation for the oil & gas refining and marketing peer group is "buy"

• Wall Street's median 12-month price target for Calumet Inc is $26.00, about 14% below its February 26 closing price of $30.22

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)